![Our work “Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion” has just been published in Angewandte Chemie International Edition. Nanozymes, nanoparticles […]](http://www.zelikin-lab.com/wp-content/uploads/2018/11/TOC_nanozymes_featured-640x300.png "Angewandte Chemie publication: Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion")
Angewandte Chemie publication: Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion
Our work “Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion” has just been published in Angewandte Chemie International Edition. Nanozymes, nanoparticles […]
News
-
Angewandte Chemie publication: Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion
Our work “Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion” has just been published in Angewandte Chemie International Edition. Nanozymes, nanoparticles […]
-
Journal of Controlled Release Publication: Combatting implant-associated biofilms through localized drug synthesis
Our work “Combatting implant-associated biofilms through localized drug synthesis” has been recently published in the Journal of Controlled Release. Bacterial contamination of implantable biomaterials is a significant socioeconomic and healthcare […]
-
Awards for MPCL students this summer!
This summer PhD students of MPCL have obtained prizes at different international conferences. At the 9th International Nanomedicine Conference, held in Sydney, PhD student Raoul Walter obtained best oral presentation […]
-
Advanced Therapeutics Publication: Bi‐Enzymatic Embolization Beads for Two‐Armed Enzyme‐Prodrug Therapy
Our work “Bi‐Enzymatic Embolization Beads for Two‐Armed Enzyme‐Prodrug Therapy” has been recently published in Advanced Therapeutics. Embolic beads, a successful tool for localized, site‐specific drug delivery, are engineered herein to […]
-
ACS Macro Letters Publication: Long-Acting, Potent Delivery of Combination Antiretroviral Therapy
Our work “Long-Acting, Potent Delivery of Combination Antiretroviral Therapy” has been published in ACS Macro Letters. Antiretroviral therapy (ART) has revolutionized HIV treatment, yet grand challenges remain: (i) short blood […]
-
ACS Applied Materials and Interfaces Publication: Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide
Our recent publication “Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide” has been published in ACS Advance Materials and Interfaces. Nitric oxide (NO) is […]
-
Journal of Controlled Release Publication: Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects
Our recent publication Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects has been published in Journal of Controlled Release. Macromolecular (pro)drugs hold […]
-
Antiviral Research Publication: The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
Our recent publication on The molecular tweezer CLR01 inhibits Ebola and Zika virus infection in collaboration with Jan Münch’s lab, in Ulm University, has been published in Antiviral Research. Ebola (EBOV) […]
-
Advanced Healthcare Materials Publication: Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses
Our recent publication on “Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses” in collaboration with Jan Münch’s lab, in Ulm University, has been published in Advanced Healthcare […]
![Our work “Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion” has just been published in Angewandte Chemie International Edition. Nanozymes, nanoparticles […]](http://www.zelikin-lab.com/wp-content/uploads/2018/11/TOC_nanozymes_featured-195x110.png "Angewandte Chemie publication: Identification and directed development of non‐organic catalysts with apparent pan‐enzymatic mimicry into nanozymes for efficient prodrug conversion")
![Our work “Combatting implant-associated biofilms through localized drug synthesis” has been recently published in the Journal of Controlled Release. Bacterial contamination of implantable biomaterials is a significant socioeconomic and healthcare […]](http://www.zelikin-lab.com/wp-content/uploads/2018/09/antibiofilm-lbl_TOC_featured-195x110.png "Journal of Controlled Release Publication: Combatting implant-associated biofilms through localized drug synthesis")
![This summer PhD students of MPCL have obtained prizes at different international conferences. At the 9th International Nanomedicine Conference, held in Sydney, PhD student Raoul Walter obtained best oral presentation […]](http://www.zelikin-lab.com/wp-content/uploads/2018/08/collage-195x110.jpg "Awards for MPCL students this summer!")
![Our work “Bi‐Enzymatic Embolization Beads for Two‐Armed Enzyme‐Prodrug Therapy” has been recently published in Advanced Therapeutics. Embolic beads, a successful tool for localized, site‐specific drug delivery, are engineered herein to […]](http://www.zelikin-lab.com/wp-content/uploads/2018/06/embolizationBeads_TOC_featured-195x110.png "Advanced Therapeutics Publication: Bi‐Enzymatic Embolization Beads for Two‐Armed Enzyme‐Prodrug Therapy")
![Our work “Long-Acting, Potent Delivery of Combination Antiretroviral Therapy” has been published in ACS Macro Letters. Antiretroviral therapy (ART) has revolutionized HIV treatment, yet grand challenges remain: (i) short blood […]](http://www.zelikin-lab.com/wp-content/uploads/2018/06/combination_TOC_featured-195x110.png "ACS Macro Letters Publication: Long-Acting, Potent Delivery of Combination Antiretroviral Therapy")
![Our recent publication “Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide” has been published in ACS Advance Materials and Interfaces. Nitric oxide (NO) is […]](http://www.zelikin-lab.com/wp-content/uploads/2018/04/localNO2_TOC_featured2-195x110.png "ACS Applied Materials and Interfaces Publication: Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide")
![Our recent publication Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects has been published in Journal of Controlled Release. Macromolecular (pro)drugs hold […]](http://www.zelikin-lab.com/wp-content/uploads/2018/02/macroRibavirin_TOC_featured-195x110.png "Journal of Controlled Release Publication: Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects")
![Our recent publication on The molecular tweezer CLR01 inhibits Ebola and Zika virus infection in collaboration with Jan Münch’s lab, in Ulm University, has been published in Antiviral Research. Ebola (EBOV) […]](http://www.zelikin-lab.com/wp-content/uploads/2018/02/CLR01_TOC_featured-195x110.png "Antiviral Research Publication: The molecular tweezer CLR01 inhibits Ebola and Zika virus infection")
![Our recent publication on “Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses” in collaboration with Jan Münch’s lab, in Ulm University, has been published in Advanced Healthcare […]](http://www.zelikin-lab.com/wp-content/uploads/2017/10/polyanion_TOC_featured-195x110.png "Advanced Healthcare Materials Publication: Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses")